Sarepta Therapeutics, Inc. (SRPT) stock analysis
SRPT · Sarepta Therapeutics, Inc.
Latest recorded price: USD 15.13
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 33.1%, free cash flow margin -14.0%, ROIC -49.4%. The model flags 2 risk signals for this company (1 high severity).